Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase.

Int J Mol Sci · 2015 · PMC4425114 · PMID 25906475

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

DPYD * 2A and c.2846A>T also showed a trend to greater toxicity with 5-FU monotherapy, mainly because of diarrhea with infusional administration and neutropenia for bolus administration of the drug. 2.2.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.